Cabana-Domínguez, Judit http://orcid.org/0000-0002-4732-7284
Bosch, Rosa
Soler Artigas, María http://orcid.org/0000-0002-3213-1107
Alemany, Silvia http://orcid.org/0000-0002-7925-6767
Llonga, Natalia http://orcid.org/0000-0003-4325-6201
Vilar-Ribó, Laura http://orcid.org/0000-0001-8758-523X
Carabí-Gassol, Pau
Arribas, Lorena
Macias-Chimborazo, Valeria
Español-Martín, Gemma
del Castillo, Clara
Martínez, Laura
Pagerols, Mireia
Pagespetit, Èlia
Prat, Raquel
Puigbó, Julia
Ramos-Quiroga, Josep Antoni
Casas, Miquel
Ribasés, Marta http://orcid.org/0000-0003-1039-1116
Article History
Received: 17 October 2023
Revised: 17 April 2024
Accepted: 22 April 2024
First Online: 23 May 2024
Competing interests
: JARQ was on the speakers’ bureau and/or acted as consultant for Biogen, Idorsia,Janssen-Cilag, Novartis, Takeda, Bial, Sincrolab, Neuraxpharm, Novartis, BMS, Medice, Rubió, Uriach, Technofarma and Raffo in the last 3 years. He also received travel awards (air tickets + hotel) for taking part in psychiatric meetings from Idorsia, Janssen-Cilag, Rubió, Takeda, Bial and Medice. The Department of Psychiatry chaired by him received unrestricted educational and research support from the following companies in the last 3 years: Exeltis, Idorsia, Janssen- Cilag, Neuraxpharm, Oryzon, Roche, Probitas, Psious, and Rubió. All other authors declare no biomedical financial interests or conflicts of interest.